2017
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial
Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith P, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K, Team H, Hargreaves J, Watson-Jones D, Godfrey-Faussett P, Cori A, Pickles M, Mandla N, Yang B, James A, Vermaak R, Makola N, Hoddinott G, Naidoo V, Bond V, Simwinga M, Mwinga A, Kosloff B, Limbada M, Bwalya J, Ngulube C, Fraser C, Eshleman S, Agyei Y, Cummings V, Catalano D, Emel L, Bunts L, Noble H, Burns D, Kouda A, Sista N, Moore A, White R, Headen T, Miller E, Hinson K, Vermund S, Barnes M, Horn L, Mwango A, Baldwin M, Wolf S, Hughes E. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. The Lancet Global Health 2017, 5: e1133-e1141. PMID: 28964756, PMCID: PMC5640509, DOI: 10.1016/s2214-109x(17)30367-4.Peer-Reviewed Original ResearchConceptsHIV-negative peopleHIV-positive individualsHIV-negative individualsAntiretroviral therapyHealth-related qualityHIV careHRQoL scoresHIV statusHerpes simplex virus type-2 statusNational InstituteHPTN 071 (PopART) studyHPTN 071 (PopART) trialLaboratory-confirmed HIVType 2 statusCross-sectional baseline surveyLarge cross-sectional surveyRecreational drug useCross-sectional surveyPresident's Emergency PlanGeneral population sampleHRQoL informationBetter HRQoLHIV-negativeHIV progressionHRQoL data
2009
Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand
Li AH, Phanuphak N, Sahasrabuddhe VV, Chaithongwongwatthana S, Vermund SH, Jenkins CA, Shepherd BE, Teeratakulpisarn N, van der Lugt J, Avihingsanon A, Ruxrungtham K, Shikuma C, Phanuphak P, Ananworanich J. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Sexually Transmitted Infections 2009, 85: 503. PMID: 19525263, PMCID: PMC3875384, DOI: 10.1136/sti.2009.036707.Peer-Reviewed Original ResearchConceptsAnal squamous intraepithelial lesionsHigh-grade squamous intraepithelial lesionsLow-grade squamous intraepithelial lesionsHIV-negative MSMSquamous intraepithelial lesionsHIV-positive MSMNegative MSMHIV-negative menIntraepithelial lesionsPositive MSMRisk factorsAnal condylomaNegative menActive antiretroviral therapy (HAART) useAbnormal anal cytologyAnal cancer precursorsAnal Pap smearsAnal precancerous lesionsAntiretroviral therapy useT-cell countsAtypical squamous cellsSignificant risk factorsAnal cytologyAsian HIVTherapy use
2002
Factors Associated With HIV Testing Among HIV-Positive and HIV-Negative High-Risk Adolescents: The REACH Study
Murphy DA, Mitchell R, Vermund SH, Futterman D. Factors Associated With HIV Testing Among HIV-Positive and HIV-Negative High-Risk Adolescents: The REACH Study. Pediatrics 2002, 110: e36-e36. PMID: 12205286, DOI: 10.1542/peds.110.3.e36.Peer-Reviewed Original ResearchConceptsUninfected adolescentsMore male partnersBlack participantsHealth care providersHealth care professionalsWhite participantsHIV testingHIV-positiveMajority of participantsHigh-risk adolescentsREACH studyWhite raceCare providersCare professionalsHIVActive adolescentsMultivariate analysisMale partnersOnly factorMale participantsAdolescentsFemale participantsMarijuana useTesting patternsAnonymous sites
2000
Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation
Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation. American Journal Of Epidemiology 2000, 152: 913-922. PMID: 11092433, DOI: 10.1093/aje/152.10.913.Peer-Reviewed Original ResearchConceptsDrug injectorsSeroprevalence levelsHIV-1 incidenceHigh-risk subgroupsHuman immunodeficiency virusBehavioral risk reductionHigh prevalence situationsImmunodeficiency virusHigh seroprevalenceSeronegativesPrevention programsRisk behaviorsInfection outbreaksSeroprevalenceInfectious outbreaksMaximum incidenceSecondary outbreaksNetwork-based mechanismsRisk reductionIncidenceOutbreakOutbreak increasesNew York CityPrevalenceYork City
1999
Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents
Douglas S, Rudy B, Muenz L, Moscicki A, Wilson C, Holland C, Crowley-Nowick P, Vermund S. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. AIDS 1999, 13: 1629-1635. PMID: 10509563, DOI: 10.1097/00002030-199909100-00005.Peer-Reviewed Original ResearchConceptsAdolescent Medicine HIV/AIDS Research NetworkHIV-negative adolescentsHIV-negative femalesHIV-positive femalesHIV-positive adolescentsAntiretroviral therapyHIV infectionHealthy adolescentsAntiretroviral therapy-naive HIVTotal CD4 cell countsThree-color flow cytometryMononuclear cell markersNaive CD8 cellsTherapy-naive HIVCD4 cell countHIV-negative subjectsHIV-positive malesAIDS Research NetworkHigh-risk HIVCD8 memory cellsNatural killer cellsTotal leukocyte countREACH cohortSeronegative adolescentsCD8 cells